Ranolazine in Ischemic Cardiomyopathy

Summary

Patients with ischemic cardiomyopathy may continue to experience persistent chest pain and shortness of breath despite conventional medical therapy and/or revascularization. The purpose of this study is to determine the efficacy of taking Ranexa versus placebo in patients with ischemic (due to blockages) cardiomyopathy treated with optimal conventional medical therapy and/or percutaneous revascularization.

Timeline

Start

2011-04

Primary completion

2014-04

Completion

2014-04

Drugs

Indications